Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach

Yuan-Ping Pang, Kun Xu, Jamal El Yazal, Franklyn G. Prendergast

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Farnesyltransferase (FT) inhibitors can suppress tumor cell proliferation without substantially interfering with normal cell growth, thus holding promise for cancer treatment. A structure-based approach to the design of improved FT inhibitors relies on knowledge of the conformational flexibility of the zinc-containing active site of FT. Although several X-ray structures of FT have been reported, detailed information regarding the active site conformational flexibility of the enzyme is still not available. Molecular dynamics (MD) simulations of FT can offer the requisite information, but have not been applied due to a lack of effective methods for simulating the four-ligand coordination of zinc in proteins. Here, we report in detail the problems that occurred in the conventional MD simulations of the zinc-bound FT and a solution to these problems by employing a simple method that uses cationic dummy atoms to impose orientational requirement for zinc ligands. A successful 1.0 ns (1.0 fs time step) MD simulation of zinc-bound FT suggests that nine conserved residues (Asn127α, Gln162α, Asn165α, Gln195α, His248β, Lys294β, Leu295β, Lys353β, and Ser357β) in the active site of mammalian FT are relatively mobile. Some of these residues might be involved in the ligand-induced active site conformational rearrangement upon binding and deserve attention in screening and design of improved FT inhibitors for cancer chemotherapy.

Original languageEnglish (US)
Pages (from-to)1857-1865
Number of pages9
JournalProtein Science
Volume9
Issue number10
StatePublished - 2000

Fingerprint

Farnesyltranstransferase
Molecular Dynamics Simulation
Molecular dynamics
Zinc
Atoms
Computer simulation
Catalytic Domain
Ligands
Neoplasms
Oncology
Chemotherapy
Cell proliferation
Cell growth
Tumors
Screening
Cell Proliferation
X-Rays
Drug Therapy
X rays

Keywords

  • Cancer research
  • Coordination chemistry
  • Drug research
  • Farnesyltransferase
  • Metalloproteins
  • Molecular dynamics
  • Zinc

ASJC Scopus subject areas

  • Biochemistry

Cite this

Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach. / Pang, Yuan-Ping; Xu, Kun; Yazal, Jamal El; Prendergast, Franklyn G.

In: Protein Science, Vol. 9, No. 10, 2000, p. 1857-1865.

Research output: Contribution to journalArticle

Pang, Yuan-Ping ; Xu, Kun ; Yazal, Jamal El ; Prendergast, Franklyn G. / Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach. In: Protein Science. 2000 ; Vol. 9, No. 10. pp. 1857-1865.
@article{18be7549c9c84080862b7d48731ceb2b,
title = "Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach",
abstract = "Farnesyltransferase (FT) inhibitors can suppress tumor cell proliferation without substantially interfering with normal cell growth, thus holding promise for cancer treatment. A structure-based approach to the design of improved FT inhibitors relies on knowledge of the conformational flexibility of the zinc-containing active site of FT. Although several X-ray structures of FT have been reported, detailed information regarding the active site conformational flexibility of the enzyme is still not available. Molecular dynamics (MD) simulations of FT can offer the requisite information, but have not been applied due to a lack of effective methods for simulating the four-ligand coordination of zinc in proteins. Here, we report in detail the problems that occurred in the conventional MD simulations of the zinc-bound FT and a solution to these problems by employing a simple method that uses cationic dummy atoms to impose orientational requirement for zinc ligands. A successful 1.0 ns (1.0 fs time step) MD simulation of zinc-bound FT suggests that nine conserved residues (Asn127α, Gln162α, Asn165α, Gln195α, His248β, Lys294β, Leu295β, Lys353β, and Ser357β) in the active site of mammalian FT are relatively mobile. Some of these residues might be involved in the ligand-induced active site conformational rearrangement upon binding and deserve attention in screening and design of improved FT inhibitors for cancer chemotherapy.",
keywords = "Cancer research, Coordination chemistry, Drug research, Farnesyltransferase, Metalloproteins, Molecular dynamics, Zinc",
author = "Yuan-Ping Pang and Kun Xu and Yazal, {Jamal El} and Prendergast, {Franklyn G.}",
year = "2000",
language = "English (US)",
volume = "9",
pages = "1857--1865",
journal = "Protein Science",
issn = "0961-8368",
publisher = "Cold Spring Harbor Laboratory Press",
number = "10",

}

TY - JOUR

T1 - Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach

AU - Pang, Yuan-Ping

AU - Xu, Kun

AU - Yazal, Jamal El

AU - Prendergast, Franklyn G.

PY - 2000

Y1 - 2000

N2 - Farnesyltransferase (FT) inhibitors can suppress tumor cell proliferation without substantially interfering with normal cell growth, thus holding promise for cancer treatment. A structure-based approach to the design of improved FT inhibitors relies on knowledge of the conformational flexibility of the zinc-containing active site of FT. Although several X-ray structures of FT have been reported, detailed information regarding the active site conformational flexibility of the enzyme is still not available. Molecular dynamics (MD) simulations of FT can offer the requisite information, but have not been applied due to a lack of effective methods for simulating the four-ligand coordination of zinc in proteins. Here, we report in detail the problems that occurred in the conventional MD simulations of the zinc-bound FT and a solution to these problems by employing a simple method that uses cationic dummy atoms to impose orientational requirement for zinc ligands. A successful 1.0 ns (1.0 fs time step) MD simulation of zinc-bound FT suggests that nine conserved residues (Asn127α, Gln162α, Asn165α, Gln195α, His248β, Lys294β, Leu295β, Lys353β, and Ser357β) in the active site of mammalian FT are relatively mobile. Some of these residues might be involved in the ligand-induced active site conformational rearrangement upon binding and deserve attention in screening and design of improved FT inhibitors for cancer chemotherapy.

AB - Farnesyltransferase (FT) inhibitors can suppress tumor cell proliferation without substantially interfering with normal cell growth, thus holding promise for cancer treatment. A structure-based approach to the design of improved FT inhibitors relies on knowledge of the conformational flexibility of the zinc-containing active site of FT. Although several X-ray structures of FT have been reported, detailed information regarding the active site conformational flexibility of the enzyme is still not available. Molecular dynamics (MD) simulations of FT can offer the requisite information, but have not been applied due to a lack of effective methods for simulating the four-ligand coordination of zinc in proteins. Here, we report in detail the problems that occurred in the conventional MD simulations of the zinc-bound FT and a solution to these problems by employing a simple method that uses cationic dummy atoms to impose orientational requirement for zinc ligands. A successful 1.0 ns (1.0 fs time step) MD simulation of zinc-bound FT suggests that nine conserved residues (Asn127α, Gln162α, Asn165α, Gln195α, His248β, Lys294β, Leu295β, Lys353β, and Ser357β) in the active site of mammalian FT are relatively mobile. Some of these residues might be involved in the ligand-induced active site conformational rearrangement upon binding and deserve attention in screening and design of improved FT inhibitors for cancer chemotherapy.

KW - Cancer research

KW - Coordination chemistry

KW - Drug research

KW - Farnesyltransferase

KW - Metalloproteins

KW - Molecular dynamics

KW - Zinc

UR - http://www.scopus.com/inward/record.url?scp=0033769641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033769641&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 1857

EP - 1865

JO - Protein Science

JF - Protein Science

SN - 0961-8368

IS - 10

ER -